key: cord-1040619-zbyoboru authors: Patkar, Nikhil; Rajpal, Sweta; Shetty, Nitin; Gokarn, Anant; Mirgh, Sumeet; Munipally, Shesheer; Nair, Sudhir; Joshi, Amit; Murthy, Vedang; Khattry, Navin; Gupta, Sudeep title: Detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is influenced by the type of transport medium: Implications for diagnosis and monitoring date: 2021-05-26 journal: Int J Clin Pract DOI: 10.1111/ijcp.14311 sha: aeca3c0ad5a6c4f95cfe0778131fbbd137e39c68 doc_id: 1040619 cord_uid: zbyoboru It is unclear if the use of a molecular transport medium (MTM) containing guanidine isothiocyanate (GITC) would be advantageous over the CDC recommended, commonly used viral transport medium (VTM). We retested 70 SARS‐CoV2 cases by RT‐PCR in varying stages of follow‐up using MTM and VTM in parallel and found discrepant results of RNase P, E and N genes. Majority (81%) patients tested positive with MTM as compared with VTM (27.1%). Even patients who were sampled 3 weeks after diagnosis demonstrated a significant discrepancy in the positivity rates between MTM vs VTM raising concerns about the clinical utility of VTM. It is unclear if the use of a molecular transport medium (MTM) containing guanidine isothiocyanate (GITC) would be advantageous over the CDC recommended, commonly used viral transport medium (VTM). We retested 70 SARS-CoV2 cases by RT-PCR in varying stages of follow-up using MTM and VTM in parallel and found discrepant results of RNase P, E and N genes. Majority (81%) patients tested positive with MTM as compared with VTM (27.1%). Even patients who were sampled 3 weeks after diagnosis demonstrated a significant discrepancy in the positivity rates between MTM vs VTM raising concerns about the clinical utility of VTM. HiViral Transport Kit, HiMedia Laboratories, Nashik, India) and a molecular transport medium (MTM, Huwel Lifesciences, Hyderabad, India) for all patients at the time of follow-up. These samples were transported to the laboratory at 4°C within 2 hours. The study was approved by the Institute Ethical Committee (ECR/149/Inst/MH/2013). We serially diluted two positive samples collected in VTM as well as MTM in samples (collected in respective transport media) which were negative for SARS-CoV-2. A normality test was performed using D'Agostino & Pearson omnibus normality test. Since the data were found to be non-Gaussian in distribution, a Wilcoxon test was used to compare differences in cycle threshold (Ct) values for the three genes assayed (E, N and RNase P) using different transport media. Graphs were generated using GraphPad Prism v6. Chi-Squared test was performed to assess discrepancies in samples collected between the two media. Figure 1A ). We grouped patients based on the week of follow-up after the original diagnosis was rendered. These patients were then grouped by E/N gene results and transport medium as seen in Figure 1D • This study highlights that the sensitivity of the RT-PCR test for SARS-COV-2 is critically dependent on the sample transport medium and is higher for MTM compared with VTM. Serial dilution of the samples collected in two transport media revealed better sensitivity with MTM with one log difference in the limit of detection for both N and E genes ( Table 1 ). RT-PCR) become negative within 21 days in majority patients after the onset of symptoms (median-14.5 days). 9 Our findings raise concerns with respect to recommendations that rely on PCR negativity from VTM sourced samples to release COVID-19 patients from isolation. Further, it is possible that transport media characteristics could contribute to discrepant results and this needs further investigation in a larger study. The authors have no conflict of interest to declare. The data that support the findings of this study are available from the corresponding author upon reasonable request. Nikhil Patkar https://orcid.org/0000-0001-9234-2857 Clinical characteristics of coronavirus disease 2019 in China Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review Transport of viral specimens Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results Evaluation of transport media and specimen transport conditions for the detection of sarscov-2 by use of real-time reverse transcription-PCR Interim Guidelines for Clinical Specimens for COVID-19 | CDC Comparison of a new transport medium with universal transport medium at a tropical field site Preanalytical issues affecting the diagnosis of COVID-19 SARS-CoV-2 detection, viral load and infectivity over the course of an infection Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is influenced by the type of transport medium: Implications for diagnosis and monitoring